Trial intelligence / Profile preview

Moxidectin for Demodex Eyelash Infestation

NCT06795165Phase 4Completed

Sponsor
Eye Research Foundation
Start
Feb 2025
Primary completion
Apr 2025
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 4 trial of moxidectin in Demodex blepharitis (DB), sponsored by Eye Research Foundation. Started Feb 2025; status: completed.

02

Drugs

moxidectin
03

Conditions

Demodex blepharitis (DB)

Beyond the preview

Go deeper on NCT06795165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06795165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call